Wells Fargo & Company Regenxbio Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

A detailed history of Wells Fargo & Company transactions in Regenxbio Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 36,152 shares of RGNX stock, worth $267,524. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,152
Previous 34,844 3.75%
Holding current value
$267,524
Previous $407,000 6.88%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
BUY
$10.49 - $14.39 $13,720 - $18,822
1,308 Added 3.75%
36,152 $379,000
Q2 2024

Aug 13, 2024
BUY
$11.51 - $21.53 $59,955 - $112,149
5,209 Added 17.58%
34,844 $407,000
Q1 2024

May 10, 2024
BUY
$12.17 - $24.61 $47,377 - $95,806
3,893 Added 15.12%
29,635 $624,000
Q4 2023

Feb 09, 2024
SELL
$12.89 - $20.82 $134,868 - $217,839
-10,463 Reduced 28.9%
25,742 $462,000
Q3 2023

Nov 13, 2023
SELL
$16.46 - $19.99 $162,015 - $196,761
-9,843 Reduced 21.38%
36,205 $595,000
Q2 2023

Aug 15, 2023
BUY
$17.23 - $21.71 $5,565 - $7,012
323 Added 0.71%
46,048 $920,000
Q1 2023

May 12, 2023
BUY
$18.08 - $24.55 $513,905 - $697,809
28,424 Added 164.29%
45,725 $864,000
Q4 2022

Feb 13, 2023
SELL
$20.4 - $24.73 $159,874 - $193,809
-7,837 Reduced 31.18%
17,301 $392,000
Q3 2022

Nov 14, 2022
SELL
$22.29 - $35.04 $13,351 - $20,988
-599 Reduced 2.33%
25,138 $665,000
Q2 2022

Aug 12, 2022
SELL
$19.35 - $35.04 $370,339 - $670,630
-19,139 Reduced 42.65%
25,737 $636,000
Q1 2022

May 16, 2022
SELL
$24.62 - $34.31 $804,360 - $1.12 Million
-32,671 Reduced 42.13%
44,876 $1.49 Million
Q4 2021

Feb 14, 2022
SELL
$30.19 - $40.28 $25,329 - $33,794
-839 Reduced 1.07%
77,547 $2.54 Million
Q3 2021

Nov 15, 2021
BUY
$29.09 - $45.68 $48,027 - $75,417
1,651 Added 2.15%
78,386 $3.29 Million
Q2 2021

Aug 16, 2021
BUY
$32.46 - $40.48 $192,552 - $240,127
5,932 Added 8.38%
76,735 $2.98 Million
Q1 2021

May 13, 2021
BUY
$33.61 - $49.95 $956,305 - $1.42 Million
28,453 Added 67.19%
70,803 $2.42 Million
Q4 2020

Feb 09, 2021
BUY
$26.52 - $49.35 $190,970 - $355,369
7,201 Added 20.49%
42,350 $1.92 Million
Q3 2020

Nov 05, 2020
SELL
$27.01 - $40.26 $217,025 - $323,489
-8,035 Reduced 18.61%
35,149 $967,000
Q2 2020

Aug 13, 2020
BUY
$27.75 - $43.44 $28,804 - $45,090
1,038 Added 2.46%
43,184 $1.59 Million
Q1 2020

May 14, 2020
BUY
$21.5 - $54.2 $906,139 - $2.28 Million
42,146 New
42,146 $1.37 Million

Others Institutions Holding RGNX

# of Institutions
196
Shares Held
43M
Call Options Held
104K
Put Options Held
478K
View Full List

About REGENXBIO Inc.

RGNX Quotes by TradingView
  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $320M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email